Summarizing historical information on controls in clinical trials

样本量测定 临床试验 统计 样品(材料) 随机对照试验 计算机科学 计量经济学 医学 数学 内科学 色谱法 化学
作者
Beat Neuenschwander,Gorana Capkun-Niggli,Michael Branson,David J. Spiegelhalter
出处
期刊:Clinical Trials [SAGE Publishing]
卷期号:7 (1): 5-18 被引量:294
标识
DOI:10.1177/1740774509356002
摘要

Historical information is always relevant when designing clinical trials, but it might also be incorporated in the analysis. It seems appropriate to exploit past information on comparable control groups.Phase IV and proof-of-concept trials are used to discuss aspects of summarizing historical control data as prior information in a new trial. The importance of a fair assessment of the similarity of control parameters is emphasized.The methodology is meta-analytic-predictive. Heterogeneity of control parameters is expressed via the between-trial variation, which is the key parameter determining the prior effective sample size and its upper bound (prior maximum sample size).For a Phase IV trial (930 control patients in 11 historical trials) between-trial heterogeneity was fairly small, resulting in a prior effective sample size of approximately 90 patients. For a proof-of-concept trial (363 patients in four historical trials) heterogeneity was moderate to substantial, resulting in a prior effective sample size of approximately 20. For another proof-of-concept trial (14 patients in one historical trial), assuming substantial heterogeneity implied a prior effective sample size of 7. The prior effective sample size can only be large if the amount of historical data is large and between-trial heterogeneity is small. The prior effective sample size is bounded by the prior maximum sample size (ratio of within- to between-trial variance), irrespective of the amount of historical data.The meta-analytic-predictive approach assumes exchangeability of control parameters across trials. Due to the difficulty to quantify between-trial variability, sensitivity of conclusions regarding assumptions and type of inference should be assessed.The use of historical control information is a valuable option and may lead to more efficient clinical trials. The proposed approach is attractive for nonconfirmatory trials, but under certain circumstances extensions to the confirmatory setting could be envisaged as well.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
吴老师完成签到 ,获得积分10
刚刚
小米发布了新的文献求助10
刚刚
李繁蕊完成签到,获得积分10
刚刚
Yego完成签到,获得积分10
刚刚
yiyiyiyiyi//完成签到,获得积分10
1秒前
1秒前
机智胡萝卜完成签到,获得积分10
1秒前
1秒前
云梦江海完成签到,获得积分10
2秒前
3秒前
汉堡包应助正直乘云采纳,获得10
3秒前
隐形曼青应助wlei采纳,获得10
3秒前
11111发布了新的文献求助10
4秒前
5秒前
sdsd发布了新的文献求助10
5秒前
故事的小红花完成签到,获得积分10
5秒前
HalfGumps完成签到,获得积分10
5秒前
fangfang发布了新的文献求助10
5秒前
7秒前
科研小土豆完成签到,获得积分10
7秒前
打打应助momucy采纳,获得10
7秒前
wzf123456完成签到,获得积分20
7秒前
Darline完成签到 ,获得积分10
8秒前
8秒前
梁海萍完成签到,获得积分10
8秒前
8秒前
9秒前
10秒前
怡宝发布了新的文献求助10
10秒前
Yao完成签到,获得积分10
10秒前
10秒前
wind完成签到 ,获得积分10
10秒前
Click完成签到,获得积分10
11秒前
yx完成签到,获得积分10
11秒前
俊逸的念桃完成签到,获得积分10
11秒前
请勿拉扯完成签到,获得积分20
11秒前
12秒前
xm完成签到,获得积分10
12秒前
哲999完成签到,获得积分10
12秒前
隐形荔枝发布了新的文献求助10
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Developing Genetic Editing Tools for Lysobacter 2000
Adhesion Science: Principles & Practice 800
Signals, Systems, and Signal Processing 610
IEST-RP-CC018: Cleanroom Cleaning and Sanitization: Operating and Monitoring Procedures 600
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 600
近红外光谱定性分析原理、技术及应用 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6531136
求助须知:如何正确求助?哪些是违规求助? 8323817
关于积分的说明 17821657
捐赠科研通 5632643
什么是DOI,文献DOI怎么找? 2932619
邀请新用户注册赠送积分活动 1909287
关于科研通互助平台的介绍 1768532